42 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Treatment • Invasive pulmonary ... • Aspergillus infections ... of eye Infectious ... Aspergillosis #Treatment #management ... #pharmacology #
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Perioperative Management ... Antirheumatic Medication ... Total Hip or Total Knee ... #rheumatology #medications ... #autoimmune #pharmacology
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Action #Asthma #Medications ... #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
Treatment of COVID-19 Infection ... smfarmhosp_smfh #Drugs #Medications ... Treatment #COVID19 #Pharmacology ... #Table #Management
Antibiotic Options for Treating MRSA Infections

PO: Doxycycline, Clindamycin, TMP-SMX, Linezolid
IV: Linezolid, Vancomycin, Ceftaroline, Daptomycin, Tigecycline

By Dr.
Treating MRSA Infections ... aureus #staph #pharmacology ... #management #microbiology ... #medications
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
C virus (HCV) infection ... treatment #hcv #medications ... HepC #HepatitisC #Management ... #Pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... InfectiousDiseases #Infections ... #Pharmacology # ... Management #Treatment ... #Indications
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... systemicsclerosis #SSc #pulmonary ... #indications #management
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Framework and Management ... Definition: 150-600 mL ... Primary Vascular: Pulmonary ... : 1) Indications ... #pulmonary #criticalcare